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Summary 
The mesothelium is a flat epithelial lining of serous cavities that could gate the traffic of molecules 
and cells between the circulation and these body compartments. The present study was designed 
to elucidate the capacity of mesothelial cells to express adhesion molecules and chemoattractant 
cytokines, two fundamental mechanisms of regulation of leukocyte recruitment. Cultured human 
mesothelial cells express appreciable levels of intercellular  adhesion molecule 1 (ICAM-1)  and 
vascular cell adhesion molecule 1 (VCAM-1),  and these were increased by in vitro exposure to 
tumor necrosis factor (TNF), interferon "y (IFN-3'), or TNF and IFN-3'. Interleukin 1 (II.-1) 
was a less consistent stimulus for adhesion molecule expression in vitro. Unlike endothelial cells, 
used as a reference cell population, resting or stimulated mesothelial cells did not express E-selectin 
and ICAM-2, as assessed  by flow cytometry. Analysis of VCAM-1 mRNA by reverse transcriptase 
and polymerase chain reaction using appropriate primers revealed that mesothelial cells expressed 
both the seven- and the six-Ig domain transcripts, with predominance of the longer species. 
Monocytes bound appreciably  to "resting" and, to a greater extent, to stimulated mesothelial 
cells. Monocytes exposed to IFN-3' and lipopolysaccharide,  used as prototypic activation signals, 
showed increased capacity to bind mesothelial cells. Anti-CD18 monoclonal antibody significantly 
inhibited binding of monocytes to mesothelial cells, and this blocking effect was amplified by 
anti-very late antigen 4. Mesothelial cells were able to express the chemotactic cytokines II.-8 
and monocyte chemotactic protein 1 at the mlLNA and protein levels. These results indicate 
that mesothelial cells can express a set of adhesion molecules (ICAM-1 and VCAM-1) overlapping 
with, but distinct from, that expressed in vascular endothelium (ICAM-1, ICAM-2, VCAM-1, 
E-selectin), and that these are functionally relevant for interacting with mononuclear phagocytes. 
The regulated expression of adhesion molecules and chemotactic cytokines by mesothelial cells 
is probably important in inflammatory and immune reactions that involve serous cavities, such 
as the long-known macrophage appearance  and disappearance  reactions. 
T 
he mesothelium is a flat epithelial lining of the perito- 
neal,  pleural, and pericardial  cavities (1). It provides a 
nonadhesive, slippery surface and gates the traffic of mole- 
cules and cells between the circulation and these body com- 
partments. 
Serous cavities can be involved by infectious, immune, and 
carcinogenic processes. Among serous surfaces, the perito- 
neal cavity has been most extensively studied as a site of im- 
mune and inflammatory reactions. Upon local application of 
infectious, inflammatory, or immune stimuli, leucocytes are 
rapidly recruited in the peritoneum. Conversely, intraperitoneal 
challenge with antigen causes rapid disappearence of mono- 
nuclear phagocytes from inflammatory exudates (macrophage 
disappearence  reaction [MDR] 1 2-7).  The MDR  can be 
mimicked by intraperitoneal injection of lymphokines that 
have not been molecularly defined (4,  7). 
Given its strategic location, it is likely that the mesothelial 
lining participates  actively in regulating leucocyte traffic be- 
tween the circulation, the peritoneal fluid, and the walls of 
the peritoneal cavity. The present study was designed to define 
the capacity of mesothelial cells to express adhesion mole- 
1 Abbreviations used in this paper: EC, endothelial cell; MCP-t, monocyte 
chemotactic protein 1; MDR, macrophage disappearance  reaction; VLA-4, 
very late antigen 4. 
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anisms of regulation of leukocyte recruitment and activation 
(for recent reviews  see references  8 and 9). 
Materials  and Methods 
Cell Culture Media and Reagents.  The following reagents were 
used for culture of cell lines, separation of effector cells, adhesion, 
and cytotoxicity  assays:  pyrogen-free  saline  for clinical  use (S.A.L.F., 
Bergamo, Italy); pyrogen-free distilled water (S.p.A. Laboratorio 
Farmacologio); RPMI 1640 (10x; Biochrom  KG, Berlin, Germany); 
IMDM; glutamine (Gibco Laboratories, Grand Island, NY); peni- 
cillin and streptomycin for clinical use (Farmitalia, Milan, Italy); 
gentamycin (Gibco Laboratories); aseptically collected FCS (Hy- 
Clone Laboratories, Logan, UT).  The routinely used tissue cul- 
ture medium was RPMI 1640 with 2 mM glutamine, 50 gg/ml 
ofgentamycin, 15% or 20% FCS, hereafter referred to as complete 
medium. All reagents contained <0.125 EU/ml of endotoxin as 
checked by the limulus amebocyte  lysate  assay  (Microbiological  As- 
sociates, WalkersviUe, MD). 
Cytoleines and Antibodies.  Human  rlL-1B (sp  act,  8  x  106 
U/ml) was obtained from Sclavo (Siena, Italy). Human rIFN-3/was 
obtained from Roche (Basel, Switzerland) or from Roussel Uclaf 
(Paris, France). Human ffNF (sp act, 8.1  x  106 U/mg) was a 
kind gift of BASF/Knoll  (Germany).  mAbs used in this study were 
obtained through the courtesy of the following persons or pro- 
duced in our laboratory by hybridomas obtained from American 
Type Culture Collection (ATCC; Rockville, MD):  two mAbs 
directed against the common B2 subunit (CD18) of  leukocyte  inte- 
grins, clone 10FI2 (Dr. J.  Ritz, Dana Farber Cancer Research 
Institute,  Boston, MA) and clone TS1/18 (ATCC); mAb anti- 
VLA-4, clone HP2/1 (IgG1) (Dr. F. Sanchez-Madrid, Hospital de 
la Princesa, Madrid, Spain); mAb anti-ICAM-1, done LB2 (IgG2b) 
(Dr. N. Hogg, Imperial  Cancer Research Fund, London, UK); mAb 
anti-VCAM-1, clone 4B9  (IgG1) (Dr. J.  Harlan,  University of 
Washington, Seattle, WA); mAb anti-ELAM-1 (E-selectin), clone 
H4/18 (IgG1) (Dr. M. Bevilacqua,  Boston, MA); mAb anti-ICAM- 
2, clone 6D5 (IgG1) (Dr. C. G. Gahmberg, University of Helsinki, 
Finland) (10); mAb directed against functional epitopes of the c~ 
chains of B2 integrins, clone CLB-LFA1/2 (CDlla) (Dr. R. van 
Lier, CLB, Amsterdam, The Netherlands), clone 44a (CD11b) (Dr. 
R. Todd, Ann Arbor, MI); and clone L29 (CD11c) (Dr. L. Lanier, 
Becton Dickinson & Co., Mountain View, CA). Appropriate ir- 
relevant antibodies, including anti-IFN-'y and anti-CD8, were used 
for flow cytometric analysis and functional assays, as detailed in 
previous reports from this laboratory (11-13). 
Mesothelial Cells.  A total of 15 mesothelial cell cultures were 
used for the present study from December 1988 to January 1992. 
Only two of these were generated from pleural or peritoneal fluids 
from nonneoplastic conditions and the remaining ones were de- 
rived from ovarian cancer ascites. The culture conditions, growth 
factor requirements, and characteristics of mesothelial cells are de- 
scribed in greater detail elsewhere (Lanfrancone  et al., manuscript 
in preparation). Ficoll-Hypaqne-separated  mononuclear cells were 
resuspended in RPMI 1640 with 15% FCS and plated in a 75-cm  2 
culture flask. After overnight incubation at 37~  the medium con- 
taining nonadherent cells (mostly erythrocytes, mononudear leu- 
kocytes, and tumor cells) was removed and cells were cultured in 
IMDM with 15% FCS and 10% PHA-conditioned medium. We 
subsequently found that RPMI 1640 could substitute for IMDM, 
and this medium, supplemented with 15% FCS, 10% conditioned 
medium, and 50 gg/ml endothelial cell growth factor (CoUabora- 
rive Research, Inc., Lexington, MA) was employed  for mesothelial 
cell culture. The conditioned medium was obtained by culturing 
human PBMC (106/ml) with I gg/ml PHA for 3 d. Under these 
conditions, tumor cells and macrophages  did not grow appreciably 
and were rapidly lost from the cultures. The medium was changed 
every 2-3 d, and the cultures, detached by trypsin/EDTA, were 
split 1:2. In these conditions they could be maintained for six to 
seven passages before they become senescent. Mesothelial cell cul- 
tures were characterized on the basis of: expression  of cytokeratins 
(mAb CAM 5.2; Becton Dickinson & Co.; DAKO-CK1 and CK- 
19; DAKOPatts, Glostrup, Denmark), carcinoembryonic antigen 
(polyclonal  anti-CEA antiserum; DAKOPatts), OC125 and Mov18 
(markers of  ovarian carcinoma cells; mAbs were gifts of Dr. R. C. 
Bast, Duke University, Durham,  NC, and Dr. M. I. Colnaghi, 
Istituto Nazionale Tumori, Milan, Italy), factor VIII and caderin 
5 (polyclonal antiserum and mAb 7B4, gifts of Dr. E. Dejana, of 
this Institute),  vimentin (DAKOvimentin, DAKOpatts), CD31 
(anti-PECAM-1, clone 9611, British Bio-Technology  Ltd., Oxford, 
England), and CD45 (mAb 9.4, NEN-DuPont Co., Wilmington, 
DE) by immunocytochemistry; expression of leukocyte differenti- 
ation antigens (CD2, CD13, CD14, CD16, CD20, HLA-DR) and 
DNA  content  by  flow  cytometry;  nonspecific esterase  by 
cytochemistry. Mesothelial cells had no karyotypic abnormality, 
did not form colonies in soft agar, and were not tumorigenic in 
nude mice. For adhesion  assays,  care  was taken to use cultures within 
the third to fourth passage, as these grew vigorously and formed 
confluent  monolayers.  Cell cultures were grown in medium without 
PHA-conditioned medium for 24-72 h (in three experiments, 7 d, 
see Results) before assays. 
Phenotyping of mesothelial cells was performed by indirect im- 
munofluorescence. Briefly, cells were exposed to mAb (5/zg/ml 
in saline with 2% human serum) specific  for different surface mol- 
ecules for 30 rain at 4~  washed, and incubated with fluoresce- 
inated  affinity-purified goat  anti-mouse  IgG  F(ab')2 (Tech- 
nogenetics, Turin, Italy) for 30 min at 4~  The cells were washed 
and fixed  with PBS containing 1% paraformaldehyde.  Fluorescence 
was measured on a FACStar Plus  |  apparatus (Becton Dickinson 
& Co.). 
Endothelial Cells. (EC).  Human EC obtained from umbilical 
veins served as a reference cell population for these studies. Their 
culture and use have been described previously (11-13). 
Leukocyte Populations.  PMN were isolated by Ficoll-Hypaque 
gradient centrifugation and gelatine sedimentation (Biochrom  KG, 
Berlin, Germany),  while lymphocytes  and monocytes  were obtained 
from Ficoll-Hypaque-separated mononuclear cells by centrifuga- 
tion on a discontinuous  (46%) gradient ofisosmotic (285 mOsmol) 
Percoll (Pharmacia, Uppsala, Sweden) (14). Monocytes were acti- 
vated by culturing 3-7 ml of a call suspension containing 3  x  106 
cells/ml complete  medium in 5-cm-diameter  Petriperm hydrophobic 
dishes (Heraeus, Vienna, Austria) for 20 h in the presence of 100 
U/m1 of IFN-3~ and 100 ng/mt of LPS. 
Adhesion.  Adhesion  ofleukocytes  to mesothelial  cells was studied 
as described  previously  for binding of  leukocytes  to endothelial  ceUs 
with minor modifications (11-13). Mesothelial cells were grown 
to confluence in flat-bottomed 96-well trays. Leukocytes (107/ml 
in complete medium) were incubated at 37~  for 1 h with 100 
#Ci SlCr (sodium chromate; Amersham, Buckinghamshire, UK). 
At the end of the incubation, the cells were washed three times 
with medium and were resuspended at 106/ml. Cells in 0.2 ml 
medium were added to mesothelial cell monolayers  and incubated 
at 37~  for 30 min, unless  otherwise specified.  When mAbs directed 
against adhesion molecules were used, they were added to leuko- 
cytes or mesothelial cells 30 rain before the adhesion test. After 
the adhesion assay, the wells were carefully washed and adherent 
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SDS. Results are presented as mean (_+ SD) percentage of adherent 
cells with  three replicates/group. 
Cytokine Production.  IL-6 was measured as hybridoma growth 
factor using 7TD1 cells  as described (15).  IL-8 was measured by 
a  commercially  available  immunometric  assay  (British  Bio- 
technology Ltd.). Monocyte chemotactic protein (MCP-1) activity 
was evaluated as the capacity of mesothelial cell  supernatants to 
induce directional migration of monocytes as described (16). 
Northern Analysis.  Mesothelial cells were detached from the cul- 
ture surface by brief exposure to trypsin/EDTA and washed repeat- 
edly in cold PBS  (2  x  107 mesothelial cells in total for each ex- 
perimental condition and at any time point). After centrifugation 
at 800 g for 10 min, total RNA was extracted from the pellet by 
the guanidine isothiocyanate method (17), with minor modifica- 
tions (16,  18). 
Total RNA (10-15 #g) was analyzed by electrophoresis through 
1% agarose-formaldehyde gels, followed by Northern blot transfer 
to Gene Screen Plus sheets (New England Nuclear, Boston, MA). 
The Ib8 and MCP-1 probes (16, 18) were labeled to high specific 
activity (10  s cpm//~g) by nick translation and ot-[3zP]dCTP (3,000 
Ci/mmol;  Amersham). Membranes were pretreated and hybrid- 
ized in 50% formamide with 10% dextran sulfate,  washed twice 
with 2x  SSC at 60~  for 30 min, and washed again twice with 
0.1x  SSC at room temperature for 30 min. The membranes were 
exposed for 24 h at  -80~  with intensifying screens. The quality 
and quantity of RNA, blotted onto filters, were checked by visual- 
ization under UV light. 
Reverse Transcriptase  (RT)-PCR.  1 #g total RNA was reverse 
transcribed and then amplified by PCR.  RNA was mixed with 
2.5 mM random hexamers in 5 mM MgClz, 25 mM KC1, 10 mM 
Tris-HC1, pH 8.3, 1 mM each dNTP, and 2.5 U/ul Moloney mu- 
rine leukemia virus RT (Perkin Elmer Cetus,  Norwalk,  CT) in 
a final volume of 20 #1. Reverse transcription was carried out at 
42~  for 15 min. This reaction was then amplified by adding in 
a final volume of 100 #1 2 mM MgC12, 50 mM KC1, 10 mM Tris- 
HC1, pH 8.3, 2.5 U Taq DNA polymerase (Perkin Elmer Cetus), 
and 0.15 M  each specific primers. Primers were as described (19): 
oligomer 370-y is  5'-GGAACCTTGCAGCTTACAGTGACAG- 
AGCTCCC-Y,  and  oligomer VC  is  16  5'-CAAGTCTACATAT- 
CACCCAAG-3'. Samples were amplified in a thermal cycler (Perkin 
Elmer Cetus) using 30 cycles at 95~  (1'), 55~  (2'), and 72~ 
(3'). 10/~1 of each RT-PCR was then subjected to electrophoresis 
through a 2% agarose gel, which was stained, photographed, and 
blotted onto Gene Screen Plus membranes. These were then hy- 
bridized to the vascular cell adhesion molecule I (VCAM-1) probe 
as described according to standard procedures for Southern blot- 
ting (20). 
Statistical Analysis.  In each functional assay, three to six repli- 
cates per experimental group were used. Results, presented as mean 
_+ SD, are representative of at least three experiments performed, 
unless otherwise specified. 
Results 
Characterization of  Mesotheliat Cells.  Mesothelial cell cul- 
tures were characterized in terms of morphology, growth prop- 
erties, DNA content,  karyotype, tumorigenicity,  and mAb- 
defined structures, in an effort to define their cell lineage and 
possible  contaminants  (Table  1,  and  data  not  shown). 
Mesothelial cultures maintained for 2-7 d  in the absence of 
growth factors had flat, cobblestone morphology, homoge- 
Table  1.  Characterization  of Mesothelial Cell Cultures 
Marker  Mesothelial cells  Monocytes 
CD2  -  - 
CD13  +  + 
CD14  -  + 
CD16  -  -  * 
CD20  -  - 
CD31  -  + 
CD45  -  + 
Class II MHC  _+*  + 
Nonspecific esterase  - s  + 
CEA  -  - 
MOV18  -  - 
Cytokeratins  +  - 
Vimentin  +  NTll 
Factor VIII  -  - 
Caderin  5  -  - 
CD2, CD13, CD14, CD16, CD20, CD31, and HLA-DR were studied 
by flow cytometry, whereas immunocytochemistry was used for cytoker- 
atins, vimentin,  CEA,  MOV18,  factor VIII, caderin 5, and CD45. 
* Mature macrophages are CD16 +  . 
Mesothelial cells were weakly (6-20%)  HLA-DR § , but culture with 
IFN-"/for 24 h resulted in >80% HLA-DR*  cells. 
S Occasionally, few esterase-positive  cells at the beginning of the culture. 
II Non tested. 
neous appearance, and no three-dimensional outgrowth. Cells 
had large nuclei with typical multiple nucleoli.  Unlike en- 
dothelial  cells,  mesothelial cells did not express factor VIII 
antigen,  CD31,  and  caderin  5  (mAb  7B4)  (Table  1). 
Moreover (see below), they expressed a distinct set of adhe- 
sion molecules.  Unlike most ovarian carcinomas (most cul- 
tures were derived from ovarian ascites), mesothelial cells were 
MOV18-  and  CEA-.  Moreover,  flow  cytometric analysis 
showed that mesothelial cell cultures had a diploid DNA con- 
tent, whereas a substantial proportion of ovarian carcinomas 
are aneuploid. Karyotype analysis of mesothelial cells revealed 
no abnormality, and these cells did not form colonies in soft 
agar and did not cause tumors in nude mice. In contrast to 
leukocyte populations, mesothelial cells did not express CD2, 
CD14,  CD16,  CD20,  CD31,  and  CD45  (Table  1).  Mono- 
cytes are shown in Table 1, as mononuclear phagocytes were 
a major contaminant at the initiation of the cultures.  Meso- 
thelial cells express CD13,  a differentiation  structure of the 
myelomonocytic pathway also present  on fibroblasts.  Only 
occasional cells at the initiation of mesothelial cultures stained 
for nonspecific esterase. Mesothelial cells were weakly HLA- 
DR. + (<5-20%),  and exposure to IFN-3, caused strong ex- 
pression of class  II MHC  (>80%  positive cells).  Typically 
mesothelial cells expressed high and low molecular weight 
cytokeratins  (7,  8,  18,  and  19)  as well  as vimentin.  Thus, 
the cultures  used for the present  study conform to criteria 
used  to identify  mesothelial  cells  (e.g.,  references  21-24). 
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Figure 1.  Expression of adhesion molecules 
on mesothelial cells. Peritoneal mesothelial cells 
were exposed to cytokines for 24 h (10 ng/ml 
IF1; 500 U/ml TNF; 500 U/ml IFN-'y), and 
expression of adhesion molecules was assessed 
by FACS  |  (.4) after staining with appropriate 
mAb or an irrelevant control mAb. Numbers 
indicate the percent positive cells and the mean 
channel of fluorescence on a linear scale. EC 
exposed to Ibl (20 ng/ml) served as reference 
population (B). EC were cultured with IL-1 for 
24 h except for E-selectin (ELAM-1), which 
was determined  at 4 h since expression subse- 
quently declined. 
In particular, morphology, ploidy, and mAb-defmed struc- 
tures distinguish mesothelial ceils from vascular endothdium, 
mononudear phagocytes,  and carcinoma cells,  and exclude 
appreciable  contamination  of cultures by these cell types. 
Expression of  Adhesion Molecules.  The expression of adhe- 
sion molecules was studied in mesothelial cells and, by way 
of comparison,  in endothelial cells. Representative experiments 
are shown in Figs.  1 and 2, and results obtained are summa- 
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Figure 2.  Expression  of ICAM-2 in EC and mesothelial  cells. Cells were exposed to medium  or TNF (500 U/ml) and IFN-~/(500 U/ml) for 24 h 
before FACS  |  analysis. Results are shown on a linear axis. 
rized in Table 2.  In the absence  of deliberate stimulation, 
mesothelial cells expressed appreciable  levels of intercellular 
adhesion molecule I (ICAM-1) and VCAM-1, whereas ICAM-2 
and E-selectin (previously designated ELAM-1) were unde- 
tectable. Unstimulated mesothelial cells were routinely main- 
tained for 24-72 h in the absence of  PHA-conditioned  medium 
before being used.  The expression of VCAM-1  may have 
resulted  from  exposure  to  cytokines  present  in  PHA- 
conditioned medium. To investigate this possibility, in three 
experiments  mesothelial  cells  were  cultured  in  medium 
Table  2.  Expression of Adhesion Molecules on Mesothelial Cells 
Adhesion 
molecule 
Endothelial cells  Mesothelial  cells 
Unstimulated  Stimulated  Unstimulated  Stimulated 
ICAM-1  +  + + +  +  + + + 
ICAM-2  +  +  -  - 
E-selectin  -  + + +  -  - 
VCAM-1  _+  + + +  + +  + + + 
Results presented summarize 10 experiments performed, except for 
ICAM-2, which  was investigated  twice. Ceils  were exposed  to TNF (500 
ng/ml) for 4-48 h. Stimulated  expression of adhesion molecules  refers 
to the 24-h time point, except for E-selectin, which peaked at 4-6 h in 
endothelial  cells. E-selectin  was undetectable  in mesothelial  cells  throughout 
the 48-h observation period. 
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without added growth factors for 7 d. Also under these con- 
ditions, appreciable  expression  of VCAM-1 was detectable 
with 10, 90, and 85% positive cells in the three assays per- 
formed (not shown). More prolonged culture in the absence 
of growth supplements resulted in gross damage of mesothelial 
cells. 
Cytokines regulate the expression  of adhesion molecules 
in vascular endothelial cells (for review, see references 8 and 
9). Therefore, mesothelial cells were exposed for 4-48 h to 
IL-1, TNF, or IFN-3~/TNF. IFN-3'/TNF augmented the ex- 
pression of ICAM-1 and VCAM-1 in mesothelial cells in all 
10 experiments performed. In contrast, I1.-1 had inconsistent 
effects: in part of the experiments (2),  II.-1 had little affect 
on adhesion molecule expression  (e.g.,  Fig.  1), whereas in 
the others, it induced augmented expression  and leukocyte 
binding (e.g.,  see Fig. 6). When optimal concentrations of 
TNF (500 U/ml) and IFN-3~ (500 U/ml) were combined, 
higher levels of adhesion molecule expression were observed. 
For instance, in the experiment shown in Fig.  1, ICAM-1 
fluorescence units at 24 h were 104 for control cells and 393, 
210, and 594 for IFN-'y-, TNF-, and IFN-'y/TNF-stimu- 
lated cells, respectively. Even when the IFN-3,/TNF combi- 
nation  was  not  dramatically better  than  the  individual 
cytokines, as for VCAM-1 at the optimal 24-h time point 
(Fig.  1), it caused a faster appearance  of the adhesion mole- 
cule compared with the two individual cytokines (Fig. 3). 
Resting or cytokine-stimulated mesothelial cells did not ex- 
press ICAM-2 and E-selectin (e.g., Figs. 1 and 2). Under the 
same conditions, in endothelial cells Ibl and TNF induced 
expression  of ELAM-1 with a peak at 4-6 h (Fig.  1 B), and 600" 
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Figure 3.  Time course of expression of adhesion molecules on mesothelial 
cells in culture. Mesothelial cells were exposed to cytokines for different 
times before analyzing adhesion molecule expression by FACS  |  Results 
are mean channel of fluorescence. 
Figure 5.  Binding of different leukocyte populations  to unstimulated 
mesothelial cells, slCr-labeled leukocytes were cultured for different times 
on monolayers of mesothelial cells previously maintained for 48 h in the 
absence of growth supplements,  After washing, the percentage of cells 
remaining  adherent to mesothelial  cells was determined. 
with early passage (greater than or equal to three) mesothelial 
cells, whereas cell preparations undergoing senescence grew 
more slowly and remained sparse. As shown in Fig. 5, among 
leukocyte populations,  monocytes showed the highest levels 
of spontaneous  binding to  unstimulated  mesothelial  cells, 
whereas PMN, NK cells, and lymphocytes  had lower adhe- 
sion.  Exposure of mesothelial  cells to cytokines  augmented 
monocyte binding considerably (Fig. 6). As expected on the 
basis of phenotype analysis (see above), maximal augmenta- 
tion of monocyte adhesion was observed when mesothelial 
these  cells  had  appreciable levels of constitutive  ICAM-2 
(Fig. 2). 
In endothelial cells, splicing results in two mRNA species 
encoding VCAM-1 molecules  with six or seven Ig domains 
(19,  25).  To identify the form(s)  of VCAM-1  expressed in 
mesothelial cells, we used RT-PCR to amplify fragments of 
different size.  As shown by the ethidium bromide-stained 
gel and the Southern blot shown in Fig. 4, mesothelial cells 
expressed a predominant 631-bp fragment and a 355-bp band; 
stimulation with TNF/IFN-3,  augmented  both bands. 
Monocyte  Binding.  Having found that mesothelial cells have 
the capacity to express adhesion molecules,  we studied the 
binding of leukocytes to confluent cultures. It should be em- 
phasized that fully confluent cultures could only be obtained 
Figure 4.  RT-PCR analysis of 
VCAM-1  transcripts  in  meso- 
thelial cells. Mesothelial cells were 
exposed to TNF (500 U/m]) and 
IFN-3, (500 U/ml) for 4 h. ID1- 
stimulated EC served as positive 
control. (Left) Ethidium bromide 
gel; (rigkt) the same after  Southern 
transfer and hybridization with a 
VCAM-1 probe. 
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Figure  6.  Binding of unstimulated  monocytes  to  cytokine-activated 
mesothelial cells. (A) Mesothelial cells were cultured for 24 h with II-1 
(10 ng/ml), TNF (500 U/ml), IFN-? (500 U/ml), or TNF/IFN-3'.  (B) 
The influence of different adhesion pathways was studied by adding ap- 
propriate mAb or control  irrelevant mAb. 
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a 110% increase  in binding in the experiment shown in Fig. 6. 
As illustrated  in Fig. 6 B, where one experiment, repre- 
sentative of three performed, is presented, anti-CD18  mAb, 
directed against the ICAM-1 and -2 counter-receptors  (26), 
caused a significant inhibition of monocyte  binding to resting 
(67% blocking) and stimulated (41% inhibition) mesothelial 
cells. A mAb directed against the (x4 B1 integrin very late 
antigen 4 (VLA-4), the VCAM-1 counter-receptor (27), had 
little or no effect alone, but in all three experiments it aug- 
mented the inhibitory activity of  anti-CD18, with 78 vs. 67% 
inhibition for "resting" mesothelium and 65 vs. 41% inhibi- 
tion for IFN-'y/TNF-stimulated mesothelial cells. When the 
role of different/~2 integrins was studied,  anti-LFA1 mAb 
inhibited monocyte binding to mesothelium, whereas anti- 
Mac-1 and anti-p150,95 had little or no effect (only two ex- 
periments performed; data not shown). 
Exposure to bacterial products or cytokines modulates the 
adhesive properties  of leukocytes, including monocytes, to 
vascular endothelium (e.g., 11-13,28). In our previous studies, 
we used LPS and IFN-3' as prototypic stimuli for the interac- 
tion of mononuclear phagocytes with endothelium (11-13). 
Monocyte activation by IFN-'y/LPS resulted in augmented 
binding  to  resting  (not  shown)  and  stimulated  (Fig. 7) 
mesothelial cells, with a 40.7% of increase in a series of five 
experiments. 
Expression of Chemotactic Cytokines.  Recruitment ofleu- 
kocytes involves the regulated expression of adhesion mole- 
cules and the response of circulating cells to tissue-derived 
chemotactic signals. It was therefore important to investigate 
whether mesothelial cells were able to express two members 
(IL-8 and MCP-1) of a recently identified chemotactic cytokine 
superfamily (for review, see reference 29). As shown in Fig. 
8, exposure to IFN-3~/TNF or IL-1 (data not shown) induced 
a substantial increase in Ib8 and MCP-1 mRNA expression 
over variable, but appreciable baseline expression. It should 
be noted that the PHA-conditioned medium used for cul- 
turing mesothelial cells augmented IL-8 expression (data not 
shown). Immunoreactive IL-8 as well as MCP-1 biological 
Figure 8.  Expression  of IL-8 
and MCP-1 in cytokine-stimulated 
mesothelial cells. Mesothelial cells 
were exposed  for 4 h to TNF (500 
U/ml) and IFN-y (500 U/ml), the 
RNA was extracted, and cytokine 
gene expression was  studied  by 
Northern analysis. 
activity  were  detected in  the  supernatant  of stimulated 
mesothelial  cells (Table 3). 
Discussion 
The  results  presented  here  demonstrate  that  human 
mesothdial cells in culture can express a defined set of adhe- 
sion molecules as well as chemoattractant cytokines, two fun- 
damental mechanisms of regulation of leukocyte traffic (8, 
9). Mesothelial cells expressed, in the absence of deliberate 
stimulation, ICAM-1 and VCAM-1, and the levels of adhe- 
sion  molecules  were augmented by TNF,  IFN-%  TNF/ 
IFN-% and Ibl, though the response to the latter stimulus 
was variable. VCAM-1 transcripts in endothelial cells undergo 
differential  splicing to yield two mRNA populations encoding 
a six- and seven-Ig domain version of the molecule (19, 25). 
The predominant version of VCAM-1 expressed on activated 
endothelium is a seven-Ig domain molecule. There is evidence 
based on gene transfer that the six-domain VCAM-1 also in- 
teracts with the leukocyte counter-receptor  VLA-4. By PCR 
t- 
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Table 3.  Production  of Cytokines by Mesothelial Cells 
Stimulus  IL-6  IL-8 
MCP-1 
(migrated 
monocytes) 
U/ral  ng  /ral 
-  1,250  120  98  •  12 
IL-1 (10 ng/ml)  22,458  _+ 2,812  NT  172  •  16 
TNF (500 U/ml)  17,892  _+ 456  580  NT 
IFN-'), (500 U/ml)  NT  160  NT 
TNF + IFN-3'  NT  600  NT 
Figure 7.  Binding of  resting  and  activated  human  monocytes  to 
mesothelial cells. Monocytes were activated by culture for 20 h with IFN-"/ 
(500 U/ml) and LPS (100 rig/m1). After washing, binding  was determined 
using cytokine (TNF/IFN-~/) activated mesothelium as substratum. 
Calls were maintained for 48 h without PHA-conditioned medium, ex- 
posed to stimuli for 20 h, washed, and cultured for further 24 h. Results 
are mean _+  SD of three  replicates, except for IL-8,  which was tested 
once.  NT, not tested. 
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seven- and six-Ig domain transcripts, with predominance of 
the longer species. Thus, the patterns of alternative splicing 
and relative abundance of VCAM-1 mRNA transcripts are 
similar in mesothelium and endothelium, with no evidence 
of tissue-specific regulation. 
It should be noted that mesothelial cells used for the present 
study were grown in the presence of conditioned medium 
of PHA-stimulated mononudear cells, a classical source of 
cytokines. Although the cells were routinely rested for 24-72 h 
(in three experiments, 7 d) before experiments, it is possible 
that the relatively high baseline expression of VCAM-1, com- 
pared with endothelial cells, may indeed result from previous 
exposure to mediators present in the growth medium. 
Unlike endothelial cells (10, 30), mesothelial cells did not 
express ICAM-2 as assessed by flow cytometry. Moreover, 
stimuli active on endothelial cells (TNF and II:1) tested repeat- 
edly at different times failed to induce E-selectin in mesothelial 
cells. Thus, the repertoire of adhesion molecules that can be 
expressed in mesothelial cells, which includes ICAM-1 and 
VCAM-1, but not ICAM-2 and E-selectin,  overlaps with, 
but is clearly distinct from, that available in the endothelial 
armamentarium. 
E-selectin acts in leukocyte-endothelium interactions as a 
lectin counter-receptor for carbohydrate-containing  molecules 
(for review, see references 8 and 9). This strong sugar-lectin 
interaction is particularly important for the rolling and ini- 
tial capture of circulating leukocytes under conditions of shear 
stress in blood vessels (31, 32). This type of interaction may 
be dispensable  in the less stressful conditions found in the 
peritoneal cavity. 
Monocyte-endothelial cell interactions can be modulated 
both at the level of vessel wall elements and circulating white 
cells. As discussed  above, at the level of the endothelium, 
inflammatory signals induce adhesion structures de novo or 
in augmented quantities. Conversely,  chemotactic agonists 
and cytokines augment the adhesive properties of mononuclear 
phagocytes (12, 13, 33-35). A similar regulated interaction 
of monocytes  with mesothelial cells was observed in the present 
study. Monocytes activated by in vitro exposure to IFN-'y 
and LPS (serving as prototypic activation signals previously 
utilized in studies on endothelium; references 12 and 13) bound 
with increased efficiency to mesothelial cells. The main f12 
integrin involved was LFA-1, with little or no contribution 
of Mac-1  and p150,95,  mAb directed against VLA-4,  the 
VCAM-1 counter-receptor, had no consistent effect on mono- 
cyte binding to mesothdium, but, when the CD18 pathway 
was blocked, a role for VLA-4-dependent adhesion was de- 
tected. These results,  paraUd to those obtained in similar 
studies with EC  (11-13,  28,  36),  establish  the functional 
significance of adhesion molecules expressed on mesothdial 
cells. 
In the present study, the functional relevance of adhesion 
molecules expressed on mesothelial cells was investigated by 
focusing on mononuclear phagocytes, a major peritoneal cell 
population. However, studies on EC have revealed that dis- 
seminating pathogens, most notably tumor cells, use the same 
adhesion pathways for interacting with endothelial cells in 
vitro and in vivo (e.g., 37-39). The peritoneal cavity can rep- 
resent a route for cancer call dissemination and a site of im- 
plantation from primary sites located in peritoneal organs, 
including the gastrointestinal tract and the ovary. In analogy 
with endothelium, the expression of adhesion structures on 
mesothelial cells is probably involved in the peritoneal dis- 
semination and seeding of cancer calls. 
Serous cavities, and most notably the peritoneum, can be 
involved by infectious, inflammatory, and immunological 
processes. It has long been known that local application of 
inflammatory or immunological stimuli can cause recruit- 
ment of leukocytes in serous cavities. Production by mesothelial 
cells of the chemotactic cytokines Ib8 and MCP-1, also ex- 
pressed by activated EC (16, 18, 40-43), can be an important 
determinant of leukocyte recruitment. On the other hand, 
intraperitoneal challenge with antigen in a peritoneum con- 
taining an inflammatory exudate resuhs in disappearance of 
macrophages from the fluid (MDK 2-7).  Lymphokine su- 
pernatants can substitute for antigen in eliciting the MDK 
(4, 7). The results presented here suggest that the inducible 
expression on the mesothdium of adhesion molecules recog- 
nized by macrophage counter-receptors underlies the MDR. 
These observations also suggest that IFN-~/and TNF may 
be central cytokine mediators of the MDK.  By and large, 
the results reported here suggest that the mesothelial lining 
plays an important, active role in regulating the traffic of leu- 
kocytes, monocytes in particular, between the circulation, the 
peritoneal fluid, and the walls of the peritoneum. 
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